Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review

COVID-19 has been affecting the world unprecedentedly and will remain widely prevalent due to its elusive pathophysiological mechanism and the continuous emergence of new variants. Critically ill patients with COVID-19 are commonly associated with cytokine storm, multiple organ dysfunction, and high...

Full description

Bibliographic Details
Main Authors: Kaixi Chang, Yupei Li, Zheng Qin, Zhuyun Zhang, Liya Wang, Qinbo Yang, Jiwen Geng, Ningyue Deng, Shanshan Chen, Baihai Su
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1074465/full
_version_ 1811173231633104896
author Kaixi Chang
Yupei Li
Zheng Qin
Zhuyun Zhang
Liya Wang
Qinbo Yang
Jiwen Geng
Ningyue Deng
Shanshan Chen
Baihai Su
Baihai Su
Baihai Su
author_facet Kaixi Chang
Yupei Li
Zheng Qin
Zhuyun Zhang
Liya Wang
Qinbo Yang
Jiwen Geng
Ningyue Deng
Shanshan Chen
Baihai Su
Baihai Su
Baihai Su
author_sort Kaixi Chang
collection DOAJ
description COVID-19 has been affecting the world unprecedentedly and will remain widely prevalent due to its elusive pathophysiological mechanism and the continuous emergence of new variants. Critically ill patients with COVID-19 are commonly associated with cytokine storm, multiple organ dysfunction, and high mortality. To date, growing evidence has shown that extracorporeal hemoadsorption can exert its adjuvant effect to standard of care by regulating immune homeostasis, reducing viremia, and decreasing endotoxin activity in critically ill COVID-19 cases. However, the selection of various hemofilters, timing of initiation and termination of hemoadsorption therapy, anticoagulation management of extracorporeal circuits, identification of target subgroups, and ultimate survival benefit remain controversial. The purpose of this narrative review is to comprehensively summarize the rationale for the use of hemoadsorption in critically ill patients with COVID-19 and to gather the latest clinical evidence in this field.
first_indexed 2024-04-10T17:44:38Z
format Article
id doaj.art-bab7f2a44fa8426aa379d328113f4344
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T17:44:38Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-bab7f2a44fa8426aa379d328113f43442023-02-03T06:07:07ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-02-011410.3389/fimmu.2023.10744651074465Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative reviewKaixi Chang0Yupei Li1Zheng Qin2Zhuyun Zhang3Liya Wang4Qinbo Yang5Jiwen Geng6Ningyue Deng7Shanshan Chen8Baihai Su9Baihai Su10Baihai Su11Department of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Nephrology, West China Hospital, Sichuan University, Chengdu, ChinaMed-X Center for Materials, Sichuan University, Chengdu, ChinaMed+ Biomaterial Institute of West China Hospital, Sichuan University, Chengdu, ChinaCOVID-19 has been affecting the world unprecedentedly and will remain widely prevalent due to its elusive pathophysiological mechanism and the continuous emergence of new variants. Critically ill patients with COVID-19 are commonly associated with cytokine storm, multiple organ dysfunction, and high mortality. To date, growing evidence has shown that extracorporeal hemoadsorption can exert its adjuvant effect to standard of care by regulating immune homeostasis, reducing viremia, and decreasing endotoxin activity in critically ill COVID-19 cases. However, the selection of various hemofilters, timing of initiation and termination of hemoadsorption therapy, anticoagulation management of extracorporeal circuits, identification of target subgroups, and ultimate survival benefit remain controversial. The purpose of this narrative review is to comprehensively summarize the rationale for the use of hemoadsorption in critically ill patients with COVID-19 and to gather the latest clinical evidence in this field.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1074465/fullCOVID-19hemoadsorptioncytokine storminflammatory mediatorsimmunomodulatoryblood purification
spellingShingle Kaixi Chang
Yupei Li
Zheng Qin
Zhuyun Zhang
Liya Wang
Qinbo Yang
Jiwen Geng
Ningyue Deng
Shanshan Chen
Baihai Su
Baihai Su
Baihai Su
Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
Frontiers in Immunology
COVID-19
hemoadsorption
cytokine storm
inflammatory mediators
immunomodulatory
blood purification
title Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
title_full Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
title_fullStr Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
title_full_unstemmed Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
title_short Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
title_sort effect of extracorporeal hemoadsorption in critically ill patients with covid 19 a narrative review
topic COVID-19
hemoadsorption
cytokine storm
inflammatory mediators
immunomodulatory
blood purification
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1074465/full
work_keys_str_mv AT kaixichang effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT yupeili effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT zhengqin effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT zhuyunzhang effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT liyawang effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT qinboyang effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT jiwengeng effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT ningyuedeng effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT shanshanchen effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT baihaisu effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT baihaisu effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview
AT baihaisu effectofextracorporealhemoadsorptionincriticallyillpatientswithcovid19anarrativereview